MacKinnon and Boone Inducted Into National Academies of Practice
The James L. Winkle College of Pharmacy congratulates Dean Neil MacKinnon, PhD, and Professor Jill Boone, PharmD, on their 2018 induction into the National Academies of Practice (NAP), as distinguished practitioners and fellows in pharmacy, a subgroup of NAP.
Fellowship in NAP is reserved for those who have spent 10 or more years of their career in the practice and delivery of health care services and who are judged by peers to have made enduring contributions to their professions.
"Dr. Boone has been a leading national and international champion for both the profession of pharmacy and for interprofessional practice. Her induction demonstrates that others outside of UC recognize her expertise and leadership in these two areas, says MacKinnon.
"This is a great honor and well-deserved recognition of the talent and leadership we have at the College of Pharmacy, says Kristi Nelson, PhD, senior vice president for academic affairs and provost at UC.
Both Boone and MacKinnon were inducted at NAPs 2018 Annual Meeting and Forum in Atlanta, held April 13-14.
Tags
Related Stories
UC experts say proper produce washing is key defense against Cyclospora
July 17, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
UC students organize free health clinic in community
July 15, 2026
The University of Cincinnati student chapter of Remote Area Medical held its annual free health clinic July 11-12 at St. Xavier High School. Medical, dental and vision care was offered to adults and children, with no income requirements or insurance needed.
University of Cincinnati advances FLASH radiation therapy with new clinical trial
July 15, 2026
UC Cancer Center researchers led the FAST-02 trial, showing ultra-high-dose-rate FLASH proton therapy near the heart and lungs safely reduced pain from thoracic bone metastases.